List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 26 June 2023

Current Report No. 26/2023

Date of preparation: 28June 2023

Subject: List of shareholders holding at least 5% of votes at the Ordinary General Meeting of the Company on 26 June 2023

The Management Board of Captor Therapeutics S.A. with its registered office in Wroclaw (the “Company”) provides the list of shareholders of the Company holding at least 5% of votes at the Ordinary General Meeting (the “OGM”) of the Company which was held on 26 June 2023:

1. Michał Walczak holding 1,496,145 votes at the OGM, constituting 43.41% of votes at the OGM and 27.93% of the total number of votes;
2. Paweł Holstinghausen Holsten holding 950,041 votes at the OGM, constituting 27.56% of votes at the OGM and 17.74% of the total number of votes;
3. Sylvain Cottens holding 526,730 votes at the OGM, constituting 15.28% of votes at the OGM and 9.83% of the total number of votes;
4. Funds Managed by Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. (Nationale-Nederlanden Dobrowolny Fundusz Emerytalny, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2025, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2030, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2035, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2040, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2050, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2045, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2055, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2060, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2065, Nationale-Nederlanden Otwarty Fundusz Emerytalny), holding 356,680 votes at the OGM, constituting 10.35% of votes at the OGM and 6.56% of the total number of votes.